Transductional Efficacy and Safety of an Intraperitoneally Delivered Adenovirus Encoding an Anti-erbB-2 Intracellular Single-Chain Antibody for Ovarian Cancer Gene Therapy

This publication has 16 references indexed in Scilit:

• Targeted tumor killing via an intracellular antibody against erbB-2.
  Journal of Clinical Investigation, 1995
• Targeted Eradication of Ovarian Cancer Mediated by Intracellular Expression of Anti-erbB-2 Single-Chain Antibody
  Gynecologic Oncology, 1995
• Oncogenes and the strategy of growth factors
  Cell, 1994
• Successful adenovirus-mediated gene transfer in an in vivo model of human malignant mesothelioma
  The Annals of Thoracic Surgery, 1994
• Reduction of erbB2 Gene-Product in Mamma Carcinoma Cell Lines by erbB2 mRNA-Specific and Tyrosine Kinase Consensus Phosphorothioate Antisense Oligonucleotides
  Biochemical and Biophysical Research Communications, 1994
• Recombinant anti-erbB2 immunotoxins containing Pseudomonas exotoxin.
  Proceedings of the National Academy of Sciences, 1992
• Aberrant expression of the c-erbB-2/neu protooncogene in ovarian cancer
  Cancer Letters, 1992
• Selection of monoclonal antibodies which induce internalization and phosphorylation of P185^HER2 and growth inhibition of cells with HER2/neu gene amplification
  International Journal of Cancer, 1991
• Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer
  Science, 1989
• Down-modulation of an oncogene protein product and reversion of the transformed phenotype by monoclonal antibodies
  Cell, 1985